Management of out-of hospital cardiac arrest patients with extracorporeal cardiopulmonary resuscitation in 2021.


Journal

Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 5 2 2021
medline: 8 5 2021
entrez: 4 2 2021
Statut: ppublish

Résumé

Over the last decade, eCPR programs have become more and more popular, at least amongst high-volume centers. Despite its rise in popularity and promising outcome, strategies concerning pre- and post-implantation of VA-ECMO remain at least debatable. Besides, integrating the appropriate set-up, managing anticoagulation, implementing LV-venting, and predicting neurological outcome play important roles in caring for thise highly selective patient-collective. We sought to present our institutional´s techniques for establishing an eCPR program and managing patients peri- and post implantation in eCPR-runs. This manuscript covers the majority of clinical concerns and parameters for establishing an eCPR program and its recent advantages. We will describe a safe way of cannulation, setting anticoagulation goals, strategies for LV-venting and ICU-treatment. Also included, an elaboration on neurological and cardiac prognostication. We advocate ultrasound-guided cannula placement in eCPR patients. Also, we emphasize the importance of using stiffer wires and smaller arterial cannula sizes due to the different physiological parameters of OHCA patients. After cannulation, we aim for lower flow goals, the concept of 'partial VA-ECMO,' and lower anticoagulatory targets. LV-venting with Impella should remain an individual case to case decision.

Identifiants

pubmed: 33538204
doi: 10.1080/17434440.2021.1886076
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-188

Auteurs

Christopher Gaisendrees (C)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Matias Vollmer (M)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Sebastian G Walter (SG)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Ilija Djordjevic (I)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Kaveh Eghbalzadeh (K)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Süreyya Kaya (S)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Ahmed Elderia (A)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Borko Ivanov (B)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Stephen Gerfer (S)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Elmar Kuhn (E)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Anton Sabashnikov (A)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Heike A Kahlert (HA)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Antje C Deppe (AC)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Axel Kröner (A)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Navid Mader (N)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Thorsten Wahlers (T)

Department of Cardiothoracic Surgery, University Hospital of Cologne, the City is Cologne (Köln), Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH